| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.34 | 1e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.34 | 5e-10 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 1e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 8e-06 |